A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease
Open Access
- 2 January 1992
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (1) , 10-16
- https://doi.org/10.1056/nejm199201023260102
Abstract
Despite the widespread use of percutaneous transluminal coronary angioplasty (PTCA), only a few prospective trials have assessed its efficacy. We compared the effects of PTCA with those of medical therapy on angina and exercise tolerance in patients with stable single-vessel coronary artery disease. Patients with 70 to 99 percent stenosis of one epicardial coronary artery and with exercise-induced myocardial ischemia were randomly assigned either to undergo PTCA or to receive medical therapy and were evaluated monthly. The patients assigned to PTCA were urged to have repeat angioplasty if their symptoms suggested re-Stenosis. After six months, all the patients had repeat exercise testing and coronary angiography. A total of 107 patients were randomly assigned to medical therapy and 105 to PTCA. PTCA was clinically successful in 80 of the 100 patients who actually had the procedure, with an initial reduction in mean percent stenosis from 76 to 36 percent. Two patients in the PTCA group required emergency coronary-artery bypass surgery. By six months after the procedure, 16 patients had had repeat PTCA. Myocardial infarction occurred in five patients assigned to PTCA and in three patients assigned to medical therapy. At six months 64 percent of the patients in the PTCA group (61 of 96) were free of angina, as compared with 46 percent of the medically treated patients (47 of 102; P<0.01 ). The patients in the PTCA group were able to increase their total duration of exercise more than the medical patients (2.1 vs. 0.5 minutes, P<0.0001) and were able to exercise longer without angina on treadmill testing (P<0.01). For patients with single-vessel coronary artery disease, PTCA offers earlier and more complete relief of angina than medical therapy and is associated with better performance on the exercise test. However, PTCA initially costs more than medical treatment and is associated with a higher frequency of complications. (N Engl J Med 1992;326:10–6.)Keywords
This publication has 28 references indexed in Scilit:
- A 10 year follow-up of single vessel angioplasty: Some important lessons and lingering questionsJournal of the American College of Cardiology, 1990
- BARI, CABRI, EAST, GABI, AND RITA: CORONARY ANGIOPLASTY ON TRIALThe Lancet, 1990
- The "second generation" NHLBI Percutaneous Transluminal Coronary Angioplasty Registry. Have we established the role for PTCA in treating coronary artery disease?Circulation, 1989
- Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patients.Circulation, 1988
- Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery BypassNew England Journal of Medicine, 1985
- Myocardial Infarction and Mortality in the Coronary Artery Surgery Study (CASS) Randomized TrialNew England Journal of Medicine, 1984
- Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trialThe American Journal of Cardiology, 1982
- Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty.Circulation, 1982
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979
- Veterans administration cooperative study of surgery for coronary arterial occlusive disease: III. Methods and baseline characteristics, including experience with medical treatmentThe American Journal of Cardiology, 1977